Reaching New Frontiers With Founding CEO & Current Director of Generate Biomedicines

Sep. 28, 2023

This article was originally published on Cowen.com

On this episode of TD Cowen’s Biotech Decoded Podcast Series, Geoff von Maltzahn, general partner at Flagship Pioneering and founding CEO and current Director of Generate Biomedicines joins Yaron Werber, Biotechnology Analyst. They discuss the AI revolution in biotech and how generative biology has impacted the drug development process. They also discuss Geoff’s approach towards designing and building companies, and building a culture centered around machine learning where data science is a driver and not just an aggregator of data. This is key given that AI models get wiser the more data flows into them, tapping into an “intelligence of scale” in which greater scale compounds discovery prowess. Press play to listen the podcast.

Subscribe to Spotify
Subscribe to Apple Podcasts

Portrait of Yaron Werber, M.D., MBA


Managing Director, Health Care – Biotechnology Research Analyst, TD Cowen

Portrait of Yaron Werber, M.D., MBA


Managing Director, Health Care – Biotechnology Research Analyst, TD Cowen

Portrait of Yaron Werber, M.D., MBA


Managing Director, Health Care – Biotechnology Research Analyst, TD Cowen

back to top